Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-02

Clinical Trial Update: Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US [Phase 4]

View source ↗

Summary

Phase IV GERD sleep study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-03-02